Celldex
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celldex and other ETFs, options, and stocks.About CLDX
Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases.
CLDX Key Statistics
Stock Snapshot
As of today, Celldex(CLDX) shares are valued at $41.95. The company's market cap stands at 3.29B, with a P/E ratio of -9.62.
On 2026-08-16, Celldex(CLDX) stock moved within a range of $40.88 to $42.75. With shares now at $41.95, the stock is trading +2.6% above its intraday low and -1.9% below the session's peak.
Trading volume for Celldex(CLDX) stock has reached 840.57K, versus its average volume of 966.95K.
The stock's 52-week range extends from a low of $20.37 to a high of $45.14.
The stock's 52-week range extends from a low of $20.37 to a high of $45.14.
CLDX News
Advertisement Why Celldex Therapeutics Stock Is Moving After Its Latest Earnings Report Celldex Therapeutics (CLDX) released second quarter and first half 202...
Earlier this week, Celldex Therapeutics reported its second quarter 2026 results, showing revenue of just US$22,000 and a net loss of US$73.5 million, alongside...
Analyst ratings
94%
of 16 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.